Detalles de la búsqueda
1.
Diabetes Accelerates Steatohepatitis in Mice: Liver Pathology and Single-Cell Gene Expression Signatures.
Am J Pathol
; 194(5): 693-707, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309428
2.
Kerr-Enhanced Optical Spring.
Phys Rev Lett
; 132(14): 143602, 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38640396
3.
RECAM-J 2023-Validation and development of the Japanese version of RECAM for the diagnosis of drug-induced liver injury.
Hepatol Res
; 54(6): 503-512, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38642343
4.
Diagnostic guide for immune checkpoint inhibitor-induced liver injury.
Hepatol Res
; 2024 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38884591
5.
Distinct roles of IL-18 and IL-1ß in murine model of macrophage activation syndrome.
J Allergy Clin Immunol
; 152(4): 940-948.e6, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37352976
6.
Treatment Outcomes of Second-Line Systemic Therapy for Neuroendocrine Prostate Cancer: A Report of Four Cases.
J UOEH
; 46(1): 23-28, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38479871
7.
Multifunctional chemical inhibitors of the florigen activation complex discovered by structure-based high-throughput screening.
Plant J
; 112(6): 1337-1349, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36288411
8.
Selenoprotein P deficiency protects against immobilization-induced muscle atrophy by suppressing atrophy-related E3 ubiquitin ligases.
Am J Physiol Endocrinol Metab
; 324(6): E542-E552, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36947851
9.
Real-world analysis of metastatic prostate cancer demonstrates increased frequency of PSA-imaging discordance with visceral metastases and upfront ARAT/docetaxel therapy.
Prostate
; 83(13): 1270-1278, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316357
10.
Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
Radiology
; 306(2): e220531, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36219111
11.
Impact of fibrosis on liver-related event incidence in nonalcoholic fatty liver disease: A multicenter observational study.
Hepatol Res
; 53(12): 1169-1184, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37534742
12.
Treatment outcome after sequential chemotherapy with cisplatin-etoposide, amrubicin and nogitecan in patients with treatment-related pure small-cell neuroendocrine prostate cancer.
Jpn J Clin Oncol
; 53(6): 522-529, 2023 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36828781
13.
Impact of cytoreductive nephrectomy prior to combination therapy of ipilimumab plus nivolumab in metastatic renal cell carcinoma.
Int J Urol
; 30(9): 746-752, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37130778
14.
Efficacy and safety of pembrolizumab and axitinib as first-line treatment for patients with advanced renal cell carcinoma: Real-world experience in Japan.
Int J Urol
; 30(9): 772-777, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37345413
15.
The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion.
Int J Urol
; 30(9): 779-786, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37317886
16.
Differential impact of proton pump inhibitor on survival outcomes of patients with advanced urothelial carcinoma treated with chemotherapy versus pembrolizumab.
Int J Urol
; 30(9): 738-745, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36693764
17.
Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.
Int J Urol
; 30(9): 730-736, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36575640
18.
Anti-inflammatory and antifibrotic effects of CBP/ß-catenin inhibitor for hepatocytes: small molecular inhibitor, OP-724 possibly improves liver function.
Med Mol Morphol
; 56(2): 94-105, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645521
19.
A novel pathologic marker, indoleamine 2,3-dioxygenase 1, for the cholangiopathy of immune checkpoint inhibitors-induced immune mediated hepatotoxicity as adverse events and the prediction of additional ursodeoxycholic acid treatment.
Med Mol Morphol
; 56(2): 106-115, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36599971
20.
Safety and Efficacy of Bis-Glyceryl Ascorbate as Prophylaxis for Hand-Foot Skin Reaction: A Single-Arm, Open-Label Phase I/II Study (DGA Study).
Oncologist
; 27(5): e384-e392, 2022 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35285503